While angiogenesis represents an important element of tissue response to ischemia or wounding and tumor-stimulated neovascularization plays a critical role in cancer's growth and expansion. At the same time relatively little new vessel growth takes place in most adult tissues including the myocardium. Although regulation of angiogenic response is an important part of normal and pathological homeostasis, little is known about the mechanisms of this control. One such control mechanism may involve the heparan sulfate matrix. Heparan sulfate proteoglycans (HSPG) can mediate both heparin- binding growth factor-receptor interaction at the cell surface as well as accumulation and storage of these growth factors in the extracellular matrix. Therefore any alteration of heparan sulfate composition on the cell surface or in the extracellular matrix can affect growth factor signaling. Recent observations have suggested that heparan sulfate chain carrying core proteins, in particular, syndecan-4, may play an important role in outside-in signaling by activating specific PKC isoenzymes and participating in PDZ domain-mediated assembly of intracellular protein complexes. In this grant application, we propose to explore these issues in the context of angiogenesis. In particular, we will study the effect of alterations in expression of heparan sulfate-carrying proteins in endothelial cells on functional properties of these cells in vitro and in vivo and investigate mechanisms responsible for these effects. It is hoped that better understanding of core protein/heparan sulfate chains control of endothelial cell function will provide new insights into the regulation of angiogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL062289-03
Application #
6390280
Study Section
Pathobiochemistry Study Section (PBC)
Program Officer
Goldman, Stephen
Project Start
1999-05-01
Project End
2001-06-30
Budget Start
2001-05-01
Budget End
2001-06-30
Support Year
3
Fiscal Year
2001
Total Cost
$43,971
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Wang, Yingdi; Baeyens, Nicolas; Corti, Federico et al. (2016) Syndecan 4 controls lymphatic vasculature remodeling during mouse embryonic development. Development 143:4441-4451
Chen, Pei-Yu; Simons, Michael (2016) When endothelial cells go rogue. EMBO Mol Med 8:1-2
Simons, Michael; Eichmann, Anne (2015) Molecular controls of arterial morphogenesis. Circ Res 116:1712-24
Baeyens, Nicolas; Mulligan-Kehoe, Mary Jo; Corti, Federico et al. (2014) Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling. Proc Natl Acad Sci U S A 111:17308-13
Ju, Rong; Zhuang, Zhen W; Zhang, Jiasheng et al. (2014) Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) and syndecan-4/syntenin pathways. J Biol Chem 289:510-9
Elfenbein, Arye; Simons, Michael (2013) Syndecan-4 signaling at a glance. J Cell Sci 126:3799-804
Lanahan, Anthony; Zhang, Xi; Fantin, Alessandro et al. (2013) The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis. Dev Cell 25:156-68
Moraes, Filipa; Paye, Julie; Mac Gabhann, Feilim et al. (2013) Endothelial cell-dependent regulation of arteriogenesis. Circ Res 113:1076-86
Corti, Federico; Finetti, Federica; Ziche, Marina et al. (2013) The syndecan-4/protein kinase C? pathway mediates prostaglandin E2-induced extracellular regulated kinase (ERK) activation in endothelial cells and angiogenesis in vivo. J Biol Chem 288:12712-21
Atri, Deepak; Larrivée, Bruno; Eichmann, Anne et al. (2013) Endothelial signaling and the molecular basis of arteriovenous malformation. Cell Mol Life Sci :

Showing the most recent 10 out of 47 publications